A randomized pharmacokinetic and pharmacodynamic trial of two regular human insulins demonstrates bioequivalence in type 1 diabetes and availability of biosimilar insulin may improve access to this medication.

Vencio S, Caiado-Vencio R, Caixeta LF, Masierek M, Mlynarski W, Drzewoski J, Gregory JM
Diabetes Obes Metab. 2022 24 (8): 1544-1552

PMID: 35441466 · DOI:10.1111/dom.14724

MeSH Terms (12)

Biosimilar Pharmaceuticals Cross-Over Studies Diabetes Mellitus, Type 1 Double-Blind Method Glucose Glucose Clamp Technique Humans Hypoglycemic Agents Insulin Insulin, Isophane Insulin, Regular, Human Therapeutic Equivalency

Connections (1)

This publication is referenced by other Labnodes entities: